Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
about
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinomaThe role of Reg IV in colorectal cancer, as a potential therapeutic targetResponsiveness of CPT-11 in respect to hMLH1 and hMSH2 protein expression in the primary colorectal cancer.Campto effective and flexible chemotherapy for advanced colorectal cancer.
P2860
Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
@en
type
label
Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
@en
prefLabel
Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
@en
P1476
Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
@en
P356
10.1016/0959-8049(96)00290-0
P478
32A Suppl 3
P577
1996-01-01T00:00:00Z